Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03911869
Title An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis (POLARIS)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Array BioPharma



Binimetinib + Encorafenib

Age Groups: adult | senior
Covered Countries USA | ITA | BEL

Additional content available in CKB BOOST